Press Release

November 09, 2022 | Press Release
Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors
October 26, 2022 | Press Release
Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology
October 19, 2022 | Press Release
CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer
October 12, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital
October 05, 2022 | Press Release
Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
September 21, 2022 | Press Release
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
August 23, 2022 | Press Release
Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund
July 13, 2022 | Press Release
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
May 27, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding
May 18, 2022 | Press Release
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO